Free Trial

Calidi Biotherapeutics (CLDI) Insider Trading & Ownership

Calidi Biotherapeutics logo
$1.68 -0.03 (-1.46%)
As of 10:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Calidi Biotherapeutics (NYSE:CLDI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.70%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$455K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$16.19K
Get CLDI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLDI Insider Buying and Selling by Quarter

Calidi Biotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2025Andrew C JacksonCFOBuy2,500$2.00$5,000.00  
8/21/2025Eric E PomaCEOBuy25,000$2.00$50,000.00  
8/21/2025James A SchoeneckDirectorBuy75,000$2.00$150,000.00  
8/21/2025Scott LeftwichDirectorBuy125,000$2.00$250,000.00  
12/17/2024Allan CamaisaCEOSell833$19.44$16,193.52  
(Data available from 1/1/2013 forward)

CLDI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Calidi Biotherapeutics includes Allan Camaisa, Andrew C Jackson, Eric E Poma, James A Schoeneck, and Scott Leftwich. Learn more on insiders at CLDI.

6.70% of Calidi Biotherapeutics stock is owned by insiders. Learn more on CLDI's insider holdings.

The following insiders have purchased CLDI shares in the last 24 months: Andrew C Jackson ($5,000.00), Eric E Poma ($50,000.00), James A Schoeneck ($150,000.00), and Scott Leftwich ($250,000.00).

Insiders have purchased a total of 227,500 CLDI shares in the last 24 months for a total of $455,000.00 bought.

The following insider sold CLDI shares in the last 24 months: Allan Camaisa ($16,193.52).

Insiders have sold a total of 833 Calidi Biotherapeutics shares in the last 24 months for a total of $16,193.52 sold.

Calidi Biotherapeutics Key Executives

  • Mr. Allan J. Camaisa (Age 64)
    CEO & Chairman of the Board
    Compensation: $306.18k
  • Ms. Wendy Pizarro Campbell Esq. (Age 53)
    Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer & Corporate Secretary
    Compensation: $295.4k
  • Dr. Boris Minev M.D. (Age 61)
    Ph.D., President of Medical & Scientific Affairs and Interim Chief Medical Officer
    Compensation: $400.1k
  • Mr. Andrew C. Jackson (Age 55)
    Chief Financial Officer
    1 recent trades
  • Dr. Amish Patel Ph.D. (Age 47)
    Senior Vice President of Technical Operations
  • Mr. Stephen Thesing (Age 58)
    Chief Business Officer


This page (NYSE:CLDI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners